Showing results (101-110 of 145) with videos related to
Sort By:
Pageof 15
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One ScaffoldCostanza Ceni, Michael J Benko, Kawthar A Mohamed, et al.Future Medicinal Chemistry|January 29, 2025
A series of benzensulfonamide derivatives as new potent carbonic anhydrase IX and XII inhibitorsSusanna Nencetti, Doretta Cuffaro, Lidia Ciccone, et al.European Journal of Medicinal Chemistry|April 13, 2011
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximesSimone Bertini, Andrea De Cupertinis, Carlotta Granchi, et al.Pharmaceuticals (Basel, Switzerland)|July 30, 2025
A Machine Learning Platform for Isoform-Specific Identification and Profiling of Human Carbonic Anhydrase InhibitorsLisa Piazza, Miriana Di Stefano, Clarissa Poles, et al.Chembiochem : a European Journal of Chemical Biology|November 1, 2013
Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitorEmilia C Calvaresi, Carlotta Granchi, Tiziano Tuccinardi, et al.Chemmedchem|August 8, 2006
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibitionFilippo Minutolo, Simone Bertini, Laura Betti, et al.Journal of Medicinal Chemistry|January 9, 2009
Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor betaFilippo Minutolo, Simone Bertini, Carlotta Granchi, et al.RSC Medicinal Chemistry|August 16, 2024
Design, synthesis and biological evaluation of arylsulfonamides as ADAMTS7 inhibitorsDoretta Cuffaro, Tina Burkhard, Bianca Laura Bernardoni, et al.Nutrition and Cancer|June 9, 2016
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma CellsStefano Fogli, Chiara Arena, Sara Carpi, et al.RSC Advances|July 14, 2015
Synthesis and biological evaluation of non-glucose glycoconjugated N-hydroyxindole class LDH inhibitors as anticancer agentsValeria Di Bussolo, Emilia C Calvaresi, Carlotta Granchi, et al.Pageof 15